US regulators are looking to infuse a relatively new regulatory data harmonization group with some major funding to help support several regulatory initiatives, including therapeutic area data ...
The US Food and Drug Administration (FDA) should adopt updated data standards that accommodate the “evolving and emerging” nature of real-world data not currently reflected in the Data Standards ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results